Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01221818 · ClinicalTrials.gov registry record · Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT01221818 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 48 participants.
The verdict
NCT01221818, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of single oral ascending doses of E6007 in healthy subjects.
Interventions
- DRUG E6007
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01221818
The ClinicalTrials.gov registry entry for NCT01221818 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which E6007 is the first listed.
NCT01221818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01221818 about?
NCT01221818 is a clinical study titled "A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects". The purpose of this study is to evaluate the safety and tolerability of single oral ascending doses of E6007 in healthy subjects.
What is the current status of trial NCT01221818?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2010-09.
What interventions are being tested in trial NCT01221818?
The interventions under investigation include: E6007 (DRUG).
Who is sponsoring clinical trial NCT01221818?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.